COMPANY NEWS
May 3, 2022
Patent registration in South Korea opens door to commercial agreements in an enormous market with high economic potential for CureLab
April 22, 2022
The university is also renewing its agreement with CureLab Oncology to support its phase II clinical trials
January 31, 2022
Partnership aims to accelerate CureLab’s clinical studies by providing access to intellectual and scientific resources that can advance research and discovery in ovarian cancer prevention and treatment strategies
November 23, 2021
Patent registration in India opens door to commercial agreements in an enormous market with rising incidence of cancer
September 16, 2021
The leading professional organization for medical oncology has selected two research presentations authored by CureLab’s science team, which is currently conducting phase II clinical study of Elenagen, an experimental DNA therapy